Gilder Gagnon Howe & Co’s Aptose Biosciences, Inc. APTO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Hold	0	–	-$1K	–	357
2020 Q3	–	Hold	0	–	–	–	341
2020 Q2	–	Hold	0	–	–	–	307
2020 Q1	–	Hold	0	–	–	–	279
2019 Q4	–	Hold	0	–	–	–	287
2019 Q3	–	Hold	0	–	–	–	306

Other funds holding APTO

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return